DPP-4 Inhibitors ('gliptins') in the Management of Type 2 Diabetes Position Statement (IMOC approved)
The DPP-4 Inhibitors ('gliptins') in the management of Type 2 Diabetes Position Statement can be found under the ‘South Yorkshire IMOC Guidance documents’ blue drop down header tab, on the South Yorkshire IMOC section of the ICB website:
South Yorkshire Integrated Medicines Optimisation Committee :: South Yorkshire I.C.B
-
Clinical support group
-
Endocrine and Diabetes
-
Do you want to add this to your CPD record?
Did you find this page helpful?